Baidu
map

RETROVIROLOGY :人类基因组中很早之前就已经植入了抗击HIV的病毒!

2017-06-28 佚名 Medicalxpress

在我们的演变过程中,病毒像今天一样,不断地感染人类。一些早期病毒融入我们的基因组,现在被称为人内源性逆转录病毒(HERV)。数百万年来,由于其遗传密码中的突变或重大缺失,它们变得惰性。目前,研究最多的HERV家族之一是HERV-K家族,自从人类和黑猩猩进化分裂以来,HERV-K家族已经活跃,有些成员可能在过去几十万年内积极地感染人类。

在我们的演变过程中,病毒像今天一样,不断地感染人类。一些早期病毒融入我们的基因组,现在被称为人内源性逆转录病毒(HERV)。数百万年来,由于其遗传密码中的突变或重大缺失,它们变得惰性。目前,研究最多的HERV家族之一是HERV-K家族,自从人类和黑猩猩进化分裂以来,HERV-K家族已经活跃,有些成员可能在过去几十万年内积极地感染人类。

HERV已成为艾滋病毒研究人员的目标,因为研究表明,T细胞在感染艾滋病毒的人体中产生针对HERV的免疫应答。现在认为HERV表达可以由HIV感染引起,并且通过针对HERV抗原而不是永久变异的HIV抗原。根据这个想法,日本熊本大学以前的研究表明,HIV-1组特异性抗原(Gag)和HERV-K Gag的组装与HIV-1的颗粒增殖和感染性降低有明显的相关性。在目前的研究中,研究人员试图以这种方式澄清HERV-K Gag如何影响HIV-1。

他们报告说,HERV-K Gag在组装的早期阶段改变后代HIV-1颗粒的大小和形态。这是因为HERV-K Gag衣壳(CA),即病毒蛋白壳,在质膜上与HIV-1Gag部分共定位(重叠)。这也导致成熟HIV-1颗粒数量减少,HIV-1释放和感染性降低。

“虽然我们发现HIV-1颗粒的释放效率和感染性受到HERV-K Gag的阻碍,”项目负责人Kazuaki Monde博士说,“它们似乎是两种独立机制的产物,HIV-1颗粒表达HERV-K Gag的细胞显着减少,但是感染性如何降低的细节仍然不清楚,需要对HERV-K CA进行更多的研究来确定如何能够降低艾滋病毒的颗粒释放和感染性 ”。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1913835, encodeId=a07219138354d, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 09 18:13:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077365, encodeId=9be720e736505, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Sat Jan 27 21:13:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217874, encodeId=492b21e874cc, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jul 02 21:57:39 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520381, encodeId=a0181520381d0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Fri Jun 30 07:13:00 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2018-05-09 ysjykql
  2. [GetPortalCommentsPageByObjectIdResponse(id=1913835, encodeId=a07219138354d, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 09 18:13:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077365, encodeId=9be720e736505, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Sat Jan 27 21:13:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217874, encodeId=492b21e874cc, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jul 02 21:57:39 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520381, encodeId=a0181520381d0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Fri Jun 30 07:13:00 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1913835, encodeId=a07219138354d, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 09 18:13:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077365, encodeId=9be720e736505, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Sat Jan 27 21:13:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217874, encodeId=492b21e874cc, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jul 02 21:57:39 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520381, encodeId=a0181520381d0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Fri Jun 30 07:13:00 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-07-02 1dd8c52fm63(暂无匿称)

    继续关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1913835, encodeId=a07219138354d, content=<a href='/topic/show?id=4684153e41f' target=_blank style='color:#2F92EE;'>#RET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15374, encryptionId=4684153e41f, topicName=RET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 09 18:13:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077365, encodeId=9be720e736505, content=<a href='/topic/show?id=cb141845040' target=_blank style='color:#2F92EE;'>#Virol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18450, encryptionId=cb141845040, topicName=Virol)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/FGFAawy0kQNXbuvUuLtUVrx5aKhOIkwqJwyxu0QlpLFIDSb1Ht19ptXvYBjuAoNBubibnNF3iazdpico7gJlbBVQg/132, createdBy=edaf2500125, createdName=ms3892185887221420, createdTime=Sat Jan 27 21:13:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217874, encodeId=492b21e874cc, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jul 02 21:57:39 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520381, encodeId=a0181520381d0, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Fri Jun 30 07:13:00 CST 2017, time=2017-06-30, status=1, ipAttribution=)]
    2017-06-30 jiyangfei

相关资讯

SCI REP:定期运动改善糖尿病患者基因组稳定性!

最后,针对T2DM患者基因表达分析表明适应性反应延长的运动训练可以提高特定基因的反应。

FRONT CELL INFECT MI:比较基因组学分析结核分枝杆菌差异

据WHO结核年报报道,2015年全球新增结核病例1,040万,死亡180万。另外,目前全球约有约20亿人口为结核菌携带者,感染者中约1/10的人最终会发展为活动性结核。结核分枝杆菌复合体(MTBC)是引发结核病的元凶,其家族成员在基因组序列上极为保守,一致性超过99%,但是不同谱系的菌株在毒力、宿主适应性等方面存在较大表型差异,这可能是MTBC菌株与不同的宿主之间长期共进化的结果。

Oncotarget:通过基因组分析神经母细胞瘤

神经母细胞瘤(Neuroblastoma,NB)是源于周围神经系统前体细胞的儿童期固体恶性肿瘤。长期以来,神经母细胞瘤治疗效果差,预后不佳,几乎占全部儿童癌症死亡的15%。因此,神经母细胞瘤又被称为“儿童肿瘤之王”。近日,国际杂志《Oncotarget》上在线发表一项通过基因组分析神经母细胞瘤的研究。

ASCO2017:炎症性肌纤维母细胞肿瘤的临床和基因组资料

炎症性肌纤维母细胞肿瘤(IMT)是形态学上穿越肿瘤和炎症界限的肿瘤。许多儿童和年轻成年人患者出现全身症状,肿瘤显示局部侵袭性甚至转移。IMTs由具成簇的有明显的淋巴浆细胞浸润的肌纤维母细胞梭形细胞的组成。

Mol Cell:杜立林实验室发现一种新的基因组保护机制

2017 年 5 月 25 日,我所杜立林实验室在《Molecular Cell》在线发表题为“SUMO-Targeted DNA Translocase Rrp2 Protects the Genome from Top2-Induced DNA Damage”的研究论文。该论文发现一个名为 Rrp2 的 DNA 移位酶通过阻止 DNA 拓扑异构酶Ⅱ(Top2)的降解来避免 Top2 毒剂(To

Nature、Cell两篇文章发现10种用于疾病诊断的CRISPR酶

最近来自加利福尼亚大学的研究人员通过研究描述了10种新型的CRISPR酶,这些酶一旦被激活其行为就像“吃豆人”一样能够“嚼碎”RNA,因此这些酶类或许能作为诊断传染性病毒的敏感检测器。这种新型的酶类是CRISPR蛋白—Cas13a的突变体,

Baidu
map
Baidu
map
Baidu
map